These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 21818010)

  • 21. The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy.
    Huo TI; Lin HC; Huang YH; Wu JC; Chiang JH; Lee PC; Lee SD
    Cancer; 2006 Jul; 107(1):141-8. PubMed ID: 16708358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
    Huo TI; Lin HC; Lee FY; Hou MC; Lee PC; Wu JC; Chang FY; Lee SD
    Liver Int; 2006 Feb; 26(1):55-61. PubMed ID: 16420510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: an Indian experience.
    Mishra P; Desai N; Alexander J; Singh DP; Sawant P
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1232-5. PubMed ID: 17688663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
    Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
    Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison and improvement of MELD and Child-Pugh score accuracies for the prediction of 6-month mortality in cirrhotic patients.
    Boursier J; Cesbron E; Tropet AL; Pilette C
    J Clin Gastroenterol; 2009 Jul; 43(6):580-5. PubMed ID: 19197195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit.
    Cholongitas E; Senzolo M; Patch D; Kwong K; Nikolopoulou V; Leandro G; Shaw S; Burroughs AK
    Aliment Pharmacol Ther; 2006 Apr; 23(7):883-93. PubMed ID: 16573791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New scoring systems for severity outcome of liver cirrhosis and hepatocellular carcinoma: current issues concerning the Child-Turcotte-Pugh score and the Model of End-Stage Liver Disease (MELD) score].
    Lee DH; Son JH; Kim TW
    Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):167-79. PubMed ID: 14515034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis.
    Huo TI; Wang YW; Yang YY; Lin HC; Lee PC; Hou MC; Lee FY; Lee SD
    Liver Int; 2007 May; 27(4):498-506. PubMed ID: 17403190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of model for end-stage liver disease for prediction of mortality in decompensated chronic hepatitis B.
    Chan HL; Chim AM; Lau JT; Hui AY; Wong VW; Sung JJ
    Am J Gastroenterol; 2006 Jul; 101(7):1516-23. PubMed ID: 16863555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The model for end-stage liver disease (MELD) predicts survival of liver cirrhosis patients after discharge to hospice.
    Antaki F; Lukowski A
    J Clin Gastroenterol; 2007 Apr; 41(4):412-5. PubMed ID: 17413612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience.
    Hassan EA; Abd El-Rehim AS
    Arab J Gastroenterol; 2013 Dec; 14(4):158-64. PubMed ID: 24433645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B; Luca A; König F; Bertolini G; Ploner M; Gridelli B; Ulbrich G; Reiberger T; Bosch J; Peck-Radosavljevic M
    Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are physician-derived disease severity indices associated with health-related quality of life in patients with end-stage liver disease?
    Kanwal F; Hays RD; Kilbourne AM; Dulai GS; Gralnek IM
    Am J Gastroenterol; 2004 Sep; 99(9):1726-32. PubMed ID: 15330910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Model for the end-stage liver disease and death prediction in a cohort of Brazilian patients on the waiting list for liver transplantation.
    Brandão A; Fuchs SC; Gleisner AL; Marroni C; Zanotelli ML; Cantisani G
    Clin Transplant; 2008; 22(5):651-6. PubMed ID: 18549449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated soluble tumor necrosis factor receptor 75 concentrations identify patients with liver cirrhosis at risk of death.
    Grünhage F; Rezori B; Neef M; Lammert F; Sauerbruch T; Spengler U; Reichel C
    Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1255-62. PubMed ID: 18995216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of prognosis of patients with decompensated liver cirrhosis using the criterion of the Model of End-Stage Liver Disease].
    Ma H; Wang H; Sun Y; Guo F; Fang JL; Shao J; Rao HY; Wang J; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):407-9. PubMed ID: 15975270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should the New Injury Severity Score replace the Injury Severity Score in the Trauma and Injury Severity Score?
    Aydin SA; Bulut M; Ozgüç H; Ercan I; Türkmen N; Eren B; Esen M
    Ulus Travma Acil Cerrahi Derg; 2008 Oct; 14(4):308-12. PubMed ID: 18988055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Model for end-stage liver disease (MELD) and allocation of donor livers.
    Wiesner R; Edwards E; Freeman R; Harper A; Kim R; Kamath P; Kremers W; Lake J; Howard T; Merion RM; Wolfe RA; Krom R;
    Gastroenterology; 2003 Jan; 124(1):91-6. PubMed ID: 12512033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical value of Child-Turcotte-Pugh and model for end-stage liver disease score to predict the prognosis of chronic severe hepatitis].
    Jiang ZS; Jiang JN
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):412-5. PubMed ID: 17631709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive risk factors for patients with cirrhosis undergoing heart surgery.
    Arif R; Seppelt P; Schwill S; Kojic D; Ghodsizad A; Ruhparwar A; Karck M; Kallenbach K
    Ann Thorac Surg; 2012 Dec; 94(6):1947-52. PubMed ID: 22921237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.